Propranolol: Expert Cardiovascular and Neurological Management
Propranolol
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.00 | $40.00 (0%) | 🛒 Add to cart |
| 20 | $2.25 | $80.00 $45.00 (44%) | 🛒 Add to cart |
| 30 | $1.67 | $120.00 $50.00 (58%) | 🛒 Add to cart |
| 60 | $0.92 | $240.00 $55.00 (77%) | 🛒 Add to cart |
| 90 | $0.67 | $360.00 $60.00 (83%) | 🛒 Add to cart |
| 120 | $0.54 | $480.00 $65.00 (86%) | 🛒 Add to cart |
| 180 | $0.44 | $720.00 $80.00 (89%) | 🛒 Add to cart |
| 270 | $0.37 | $1080.00 $100.00 (91%) | 🛒 Add to cart |
| 360 | $0.33
Best per pill | $1440.00 $120.00 (92%) | 🛒 Add to cart |
| Product dosage: 80mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.50 | $45.00 (0%) | 🛒 Add to cart |
| 20 | $2.50 | $90.00 $50.00 (44%) | 🛒 Add to cart |
| 30 | $1.83 | $135.00 $55.00 (59%) | 🛒 Add to cart |
| 60 | $1.00 | $270.00 $60.00 (78%) | 🛒 Add to cart |
| 90 | $0.72 | $405.00 $65.00 (84%) | 🛒 Add to cart |
| 120 | $0.67 | $540.00 $80.00 (85%) | 🛒 Add to cart |
| 180 | $0.56 | $810.00 $100.00 (88%) | 🛒 Add to cart |
| 270 | $0.46 | $1215.00 $125.00 (90%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $1620.00 $155.00 (90%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
Propranolol is a non-selective beta-adrenergic blocking agent, representing a cornerstone in the therapeutic management of a spectrum of cardiovascular and neurological conditions. As a first-generation beta-blocker, its mechanism of action involves competitive antagonism of catecholamines at both β₁- and β₂-adrenergic receptor sites. This foundational activity underpins its efficacy in modulating heart rate, myocardial contractility, and blood pressure, while its high lipophilicity facilitates penetration of the blood-brain barrier, enabling significant central nervous system effects. This comprehensive profile makes it an indispensable tool for clinicians managing hypertension, angina pectoris, cardiac arrhythmias, migraine prophylaxis, essential tremor, and symptom control in thyrotoxicosis and anxiety disorders. Its established safety profile and extensive clinical history support its continued use in both acute and chronic treatment regimens.
Features
- Pharmacological Class: Non-selective beta-adrenergic receptor blocker.
- Mechanism of Action: Competitively blocks catecholamine effects at β₁- (cardiac) and β₂- (bronchial, vascular) adrenergic receptors.
- Bioavailability: Approximately 25% due to significant first-pass metabolism in the liver.
- Half-life: Elimination half-life is 3 to 6 hours following oral administration.
- Protein Binding: Heavily protein-bound (90-95%).
- Metabolism: Primarily hepatic via the cytochrome P450 system (CYP2D6, CYP1A2, CYP2C19), leading to active metabolites.
- Excretion: Principally renal excretion of metabolites.
- Formulations: Available in immediate-release (IR) tablets and long-acting sustained-release (SR) capsules.
Benefits
- Effective Blood Pressure Control: Reduces systolic and diastolic blood pressure by decreasing cardiac output and inhibiting renin release from the kidneys.
- Reduced Myocardial Oxygen Demand: Lowers heart rate and contractility, providing prophylactic management of angina pectoris.
- Cardioprotection Post-Myocardial Infarction: Long-term administration in stable patients reduces the risk of reinfarction and mortality.
- Control of Cardiac Arrhythmias: Suppresses ectopic pacemaker activity and slows conduction through the atrioventricular (AV) node to manage supraventricular tachycardias.
- Prophylaxis of Migraine Headaches: Significantly reduces the frequency and severity of migraine episodes through presumed effects on cerebral vasculature and central mechanisms.
- Symptomatic Management of Essential Tremor and Situational Anxiety: Attenuates the peripheral adrenergic component of tremor and autonomic symptoms of anxiety (e.g., tachycardia, palpitations).
Common use
Propranolol is indicated for the management of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is a fundamental treatment for angina pectoris, improving exercise tolerance and reducing attack frequency. It is employed in the management of various cardiac arrhythmias, including supraventricular tachycardia, atrial fibrillation, and flutter for ventricular rate control. Furthermore, it is FDA-approved for the prophylaxis of common migraine headaches. Off-label, it is widely used for the symptomatic control of essential tremor, the management of performance or situational anxiety, and as an adjunct therapy for the symptoms of hyperthyroidism (e.g., tachycardia, tremor).
Dosage and direction
Dosage is highly individualized based on the indication, patient response, and tolerance. Therapy should be initiated at a low dose and titrated upward gradually.
- Hypertension: Initial dose is often 40 mg IR twice daily or 80 mg SR once daily. The maintenance dose range is typically 120-240 mg per day administered in divided doses (IR) or as a single daily dose (SR). Maximum doses may reach 640 mg/day in some cases.
- Angina Pectoris: Starting dose is 80 mg IR per day in divided doses or 80 mg SR once daily. The usual effective dose range is 160-240 mg per day.
- Arrhythmias: 10-30 mg IR three or four times daily, before meals and at bedtime.
- Migraine Prophylaxis: Initial dose is 80 mg per day (IR in divided doses or SR). The therapeutic range is 160-240 mg per day. The dosage may be divided for the IR formulation.
- Essential Tremor: Starting dose is 40 mg IR twice daily. Maintenance doses are typically 120-320 mg per day in divided doses.
Administration: Immediate-release tablets should be taken consistently, either always with food or always on an empty stomach to minimize variability in absorption. Sustained-release capsules must be swallowed whole and not crushed, chewed, or opened. Abrupt discontinuation of propranolol should be avoided; therapy should be withdrawn gradually over a period of 1-2 weeks under medical supervision to prevent rebound hypertension or angina.
Precautions
Patients should be closely monitored, especially during initiation and titration of therapy. Caution is advised in patients with a history of heart failure, as beta-blockers can depress myocardial contractility. Use with caution in patients with diabetes mellitus, as propranolol can mask important signs of hypoglycemia (e.g., tachycardia) and may potentiate insulin-induced hypoglycemia. It may also mask signs of hyperthyroidism. Propranolol can cause bradycardia and hypotension; heart rate and blood pressure should be monitored regularly. Patients should be advised that propranolol can cause fatigue, dizziness, and lightheadedness, which may impair mental alertness or physical coordination, especially at the start of treatment.
Contraindications
Propranolol is contraindicated in patients with:
- Cardiogenic shock.
- Sinus bradycardia and greater than first-degree heart block.
- Bronchial asthma or a history of severe chronic obstructive pulmonary disease (COPD).
- Decompensated or overt cardiac failure (unless the failure is secondary to a tachyarrhythmia treatable with propranolol).
- Hypersensitivity to propranolol or any component of the formulation.
- Severe peripheral arterial circulatory disorders.
Possible side effect
The majority of adverse reactions are dose-dependent and result from the drug’s pharmacological beta-blocking action.
- Common (>1%): Bradycardia, cold extremities, fatigue, dizziness, insomnia, vivid dreams or nightmares, nausea, diarrhea or constipation.
- Less Common: Depression, memory disturbance, hallucinations, bronchospasm (in susceptible individuals), worsening of heart failure, hypotension, Raynaud’s phenomenon, rash, impotence or decreased libido.
- Rare: Agranulocytosis, thrombocytopenic purpura, alopecia, Peyronie’s disease.
Drug interaction
Propranolol has a significant potential for drug interactions due to its metabolism and mechanism.
- CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine, Quinidine): Can increase propranolol plasma concentrations, potentiating its effects and side effects.
- Other Antihypertensives (e.g., Calcium channel blockers like Verapamil/Diltiazem, Alpha-blockers): May lead to additive hypotensive effects and/or bradycardia. Concomitant use with verapamil can cause severe hypotension and heart block.
- Insulin and Oral Hypoglycemics: Propranolol can enhance hypoglycemic effects and mask tachycardia, a key sign of hypoglycemia.
- Sympathomimetics (e.g., Epinephrine, Albuterol): Propranolol can antagonize the bronchodilator effects of beta-agonists and potentially lead to unopposed alpha-adrenergic activity (e.g., severe hypertension with epinephrine).
- NSAIDs (e.g., Ibuprofen, Naproxen): May attenuate the antihypertensive effect of propranolol.
- Warfarin: May increase warfarin concentration and prolong prothrombin time.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. The patient should not take a double dose to make up for the missed one.
Overdose
Symptoms of overdose are primarily extensions of the drug’s beta-blocking activity and include severe bradycardia, hypotension, congestive heart failure, bronchospasm, hypoglycemia, and seizures. Cardiac arrest may occur. In cases of significant overdose, treatment is supportive and symptomatic. Advanced life support measures may be required. Atropine can be administered for bradycardia. Glucagon is considered a first-line antidote as it can increase heart rate and blood pressure through a non-catecholamine pathway. In refractory cases, vasopressors like epinephrine or dobutamine may be used with extreme caution.
Storage
Store at controlled room temperature (20°-25°C or 68°-77°F), in a tight, light-resistant container. Keep out of reach of children and pets. Do not use after the expiration date printed on the container. Properly discard any unused medication.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
- Clinical Efficacy (Cardiology): “Propranolol remains a gold-standard therapy for rate control in atrial fibrillation and for secondary prevention post-MI. Its non-selectivity provides a broad hemodynamic effect, though requires vigilance in patients with reactive airways.” – Cardiologist, 15 years experience.
- Neurological Application: “For prophylactic migraine management, it is one of our most effective and well-tolerated first-line options. The sustained-release formulation greatly improves adherence.” – Neurologist, 10 years experience.
- Primary Care Perspective: “Its utility in managing the somatic symptoms of anxiety and essential tremor is invaluable in primary care. The key is slow titration to minimize initial fatigue and dizziness.” – General Practitioner, 8 years experience.
- Patient Experience (Hypertension): “After trying several medications, propranolol was the one that consistently controlled my blood pressure with minimal side effects once my body adjusted. The vivid dreams were strange at first but subsided.” – Patient, 54.
- Patient Experience (Migraine): “It cut my migraine frequency in half. The difference in my quality of life has been profound. I experienced some tiredness for the first month, but it was a worthwhile trade-off.” – Patient, 38.